Bank Of New York Mellon Corp Palatin Technologies Inc Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$0.68 - $1.25 $27,244 - $50,082	-40,066 Reduced 28.35%	101,252 $69,000
Q4 2020 Feb 09, 2021	SELL	$0.38 - $0.78 $2,280 - $4,680	-6,001 Reduced 4.07%	141,318 $96,000
Q3 2020 Nov 12, 2020	BUY	$0.47 - $0.64 $16,738 - $22,792	35,613 Added 31.88%	147,319 $69,000
Q2 2020 Aug 12, 2020	SELL	$0.41 - $0.73 $204,618 - $364,321	-499,070 Reduced 81.71%	111,706 $56,000
Q1 2020 May 06, 2020	BUY	$0.36 - $0.79 $22,380 - $49,112	62,168 Added 11.33%	610,776 $256,000
Q4 2019 Feb 14, 2020	SELL	$0.75 - $0.89 $122,174 - $144,980	-162,899 Reduced 22.89%	548,608 $427,000
Q3 2019 Nov 07, 2019	SELL	$0.78 - $1.09 $15,831 - $22,123	-20,297 Reduced 2.77%	711,507 $647,000
Q2 2019 Aug 12, 2019	SELL	$0.98 - $1.64 $7,203 - $12,054	-7,350 Reduced 0.99%	731,804 $849,000
Q1 2019 May 14, 2019	BUY	$0.67 - $1.01 $25,606 - $38,600	38,218 Added 5.45%	739,154 $724,000
Q4 2018 Feb 11, 2019	BUY	$0.63 - $1.0 $103,088 - $163,633	163,633 Added 30.45%	700,936 $496,000
Q3 2018 Nov 09, 2018	BUY	$0.88 - $1.1 $22,150 - $27,688	25,171 Added 4.91%	537,303 $0
Q2 2018 Aug 06, 2018	BUY	$0.91 - $1.45 $337,861 - $538,350	371,276 Added 263.59%	512,132 $497,000
Q1 2018 May 15, 2018	BUY	$0.84 - $1.18 $12,538 - $17,613	14,927 Added 11.85%	140,856 $154,000
Q4 2017 Feb 09, 2018	BUY	$0.68 - $1.0 $85,631 - $125,929	125,929	125,929 $108,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.3M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.